Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3

Growth Hormone and IGF Research

Volumn 10, Issue SUPPL. A, 2000, Pages

  Baxter, R C ^a   Butt, A J ^a   Schedlich, L J ^a   Martin, J L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; DNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RETINOIC ACID; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D DERIVATIVE;

APOPTOSIS; BREAST CANCER; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CONFERENCE PAPER; DNA SYNTHESIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033889365     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(00)90004-2     Document Type: Conference Paper

References (5)

1. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line
2. Structural determinants of ligand and cell-surface binding of insulin-like growth factor-binding protein-3
3. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
4. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
5. The IGF axis and programmed cell death